Volunteering at M. D. Anderson
Treatment Options for Lymphedema Patients
NCCN Receives $4 Million In Oncology Research Funding From GlaxoSmithKline
The National Comprehensive Cancer Network (NCCN) has been awarded two individual $2 million grants from GlaxoSmithKline (GSK) to support clinical studies of ofatumumab (Arzerra®, GlaxoSmithKline) in the treatment of hematologic malignancies and pazopanib (Votrient®, GlaxoSmithKline) in the treatment of solid tumors...
Early Detection: Undiagnosed Breast Clinic
New Molecular Marker Could Predict If Breast Cancer Patients Need Chemotherapy
A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists...
Abraxis BioScience And Specialised Therapeutics Announce Approval To Market ABRAXANE For Metastatic Breast Cancer In New Zealand
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, and Specialised Therapeutics Ltd. today announced that MEDSAFE, the New Zealand Medicines and Medical Devices Safety Authority, has approved for marketing ABRAXANE® (nanoparticle albumin-bound paclitaxel) for the treatment of metastatic breast cancer after failure of anthracycline therapy...
Motivating Men To Seek Cancer Screening
In Germany, several national health campaigns promote cancer screening by announcing that only one in five German men gets screened. This is supposed to motivate men to have an examination...
Zetiq Reports CE Conformity For Its Cervical Cancer Diagnostic Kit
Zetiq Technologies Ltd. ("Zetiq"), a subsidiary of Bio-Light Ltd. (TASE: BOLT), reports that it has fulfilled the essential requirements towards issuing a self declaration CE mark of conformity for its diagnostic product for identification of cervical cancer in cytological specimens...
Experts Concerned About Increase In HPV-Related Head And Neck Cancers
The human papillomavirus increasingly is being identified as the cause of head and neck cancers, prompting some physicians to guess that the genesis of the cancers might be oral sex, the Raleigh News & Observer reports. David Brizel, an oncologist at Duke University who specializes in head and neck cancers, said, "A third of head and neck cancers we see nowadays are [related to] HPV...
Synta Announces STA-9090 Results Published In Journal "Blood" Demonstrating Potent In Vitro And In Vivo Activity In AML
Synta Pharmaceuticals Corp...